Zevra Therapeutics, Inc. ZVRA Total costs & expenses

Total costs & expenses at other companies

BioMarin PharmaceuticalsBMRN

$878.79M+60.2%

Rigel PharmaceuticalsRIGL

$46.93M+15.7%

XER

Xeris Biopharma Holdings, Inc.XERS

$86.93M+29.6%

ANI PharmaceuticalsANIP

$225.58M+14.2%

LQD

Liquidia CorporationLQDA

$86.16M+85.9%

BridgeBio PharmaBBIO

$350.76M+43.3%

FAQ

What is Zevra Therapeutics, Inc.'s total costs & expenses?

Zevra Therapeutics, Inc. (ZVRA) reported total costs & expenses of $21.05M in Q2 2026.

How has Zevra Therapeutics, Inc.'s total costs & expenses changed year-over-year?

Zevra Therapeutics, Inc.'s total costs & expenses decreased by 13.1% year-over-year, from $24.22M to $21.05M.

What is the long-term trend for Zevra Therapeutics, Inc.'s total costs & expenses?

Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s total costs & expenses has grown at a 44.2% compound annual growth rate (CAGR), from $20.92M to $90.36M.

What does total costs & expenses mean?

This metric aggregates all operating costs incurred to support the business, including cost of product revenue, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the company's operational burn rate and efficiency in managing its cost structure. Tracking this helps evaluate the scalability of the business model relative to revenue growth.